Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Evolus Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Evolus Inc. June 5, 20250.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Evolus Inc. | Grant or award | +45,559 | — | — |
| Mar 7, 2025 | Evolus Inc. | Grant or award | +7,364 | — | — |
| May 14, 2024 | Evolus Inc. | Open-market sale | −6,718 | $12.60 | $84,647 |
| May 13, 2024 | Evolus Inc. | Open-market sale | −3,643 | $12.72 | $46,339 |
| Feb 7, 2024 | Evolus Inc. | Grant or award | +6,464 | — | — |
| Jan 27, 2023 | Evolus Inc. | Grant or award | +8,293 | — | — |
Questions about David N. Gill
What boards is David N. Gill on?
David N. Gill sits on the boards of Evolus Inc. and Telix Pharmaceuticals Limited.
How long has David N. Gill served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.